Jan 21, 2017 at 15:06 | Source: CNBC-TV18
CNBC-TV18's poll shows FMCG major's net profit will shrink 0.5 percent in the December quarter; demonetisation likely to hit business as margins may fall 40 basis points to 18% in Q3.
Jan 19, 2017 at 16:26 | Source: Moneycontrol.com
EBITDA in Q3 is likely to fall 4 percent at Rs 1927 crore against Rs 2008 crore while margins may stand at 31.8 percent versus 32.4 percent year-on-year.
Jan 18, 2017 at 19:44 | Source: PTI
Sterlite Tech posts 63 percent net profit growth in Q3 FY'17; sales cross 100 countries. Strong operating performance with revenue up 23 percent and PAT up 63 percent vs Q3 FY'16.
Jan 17, 2017 at 17:20 | Source: Moneycontrol.com
In line earnings. Reliance's 3QFY17 EBITDA and net profit were largely in line with our estimates. Slight miss in refining EBITDA was offset by better than expected performance by petrochemical segment. Net profit was helped by particularly high other income in the quarter, likely due to the mark-to-market impact under Ind-AS.
Jan 17, 2017 at 15:28 | Source: Moneycontrol.com
Software firm Mastek's third quarter profit on consolidated basis jumped 46.8 percent sequentially to Rs 11.2 crore, driven by strong operational performance and tax write-back.
Jan 16, 2017 at 16:11 | Source: Moneycontrol.com
JM Financial feels Bharti Airtel may see lower impact of demonetisation as well as the ramp up of user base by Reliance Jio due to lower operating costs, rural exposure and non-mobile EBITDA, among others.
Jan 16, 2017 at 11:47 | Source: CNBC-TV18
Software services provider NIIT Technologies' third quarter profit is seen rising 7 percent sequentially to Rs 63 crore on reversal of provision but topline and operational performance may be week.
Jan 16, 2017 at 09:40 | Source: Moneycontrol.com
Goldman Sachs maintains buy call on Coal India with a target of Rs 360 per share as increase in coking coal prices augurs well for margins. It is expecting 5-13 percent higher EBITDA for FY17-19. It forecasts 7 percent production CAGR over the next ten years.
Jan 15, 2017 at 14:20 | Source: PTI
Pharma companies are likely toreport sequentially flat EBITDA growth in 3QFY17, impacted bypricing pressure and higher R&D expenditure, a report said.
Jan 09, 2017 at 12:16 | Source: CNBC-TV18
In the second half of FY17, the company is expecting EBITDA per tonne of Rs 6,000-6,500, said MD & CEO Dilip Oommen. In first half, the EBITDA per tonne was Rs 4,500.